News

Epicentre’s contribution to addressing TB diagnostics and therapeutics gaps in Low Income Countries

Niger, with Epicentre as project leader, officially joins the Organization for Women in Science for the Developing World in Niger.

After years of progress, the fight against malaria has slowed down in 2020. For the first time in 20 years, the number of cases has increased, most li...

During this webinar, on 10 May at 11am (Paris Time) on Zoom in French and English, you will discover the results of the survey on vaccination coverage...

Two recent drugs, bedaquiline and delamanid, are changing the game for patients with multidrug-resistant tuberculosis. Two studies of the endTB consor...

With the support of ANRS (French Agency for Research on AIDS and Viral Hepatitis), Epicentre and MSF are evaluating a new test, FujiLAM, to diagnose T...

Despite improvements in the management of childhood severe acute malnutrition, coverage of treatment programs remains low. Distance to outpatient clin...

Corinne Tchoula, who recently received her PhD in biochemistry, already has a well-rounded scientific career. After having been inspired and supported...

While Malawian women are at high risk of cervical cancer, screening campaigns are not entirely meeting their objectives. An Epicentre survey explores ...

Sleeping sickness is one of the so-called neglected tropical diseases, as it generally affects populations in low- and middle-income countries and rec...